With 0.74 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.33 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $0.6734 whereas the lowest price it dropped to was $0.5801. The 52-week range on IBO shows that it touched its highest point at $6.17 and its lowest point at $0.36 during that stretch. Beta for the stock currently stands at 5.59.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of IBO was up-trending over the past week, with a rise of 13.24%, but this was up by 5.09% over a month. Three-month performance surged to 17.16% while six-month performance fell -67.50%.
Float and Shares Shorts:
At present, 12.19 million IBO shares are outstanding with a float of 12.08 million shares on hand for trading. On 2025-08-15, short shares totaled 0.21 million, which was 176.0 higher than short shares on 1752537600. In addition to Mr. Frank D. Heuszel Esq., J.D. as the firm’s Chairman & CEO, Mr. Todd D. Macko CPA serves as its CFO, Secretary & Treasurer.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2025-06-30, IBO reported revenue of $7000.0 and operating income of -$1153000.0. The EBITDA in the recently reported quarter was -$13804000.0 and diluted EPS was -$1.18.
